REX加密股票溢价收益主动型ETF CEPI 深 沪
已收盘 02-06 16:00:00 美东时间
31.8029
+2.443
+8.32%
华盛通- 最 高31.8029
- 今 开30.00
- 成交量 4.73万股
- 最 低 30.00
- 昨 收 29.36
- 总市值 8554.98万
- 52周最高 38.4913
- 市盈率 静 --
- 换手率 1.76%
- 52周最低 17.736
- 委 比 -95.92%
- 总股本 269.00万
- 历史最高 34.8265
- 量 比 0.60
- 振 幅 6.14%
- 历史最低 17.736
- 每 手 1
- 风险率 4.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Cepi And Samsung Biologics Collaborate To Strengthen Outbreak-Ready Vaccine Production And Global Access
BRIEF-Cepi And Samsung Biologics Collaborate To Strengthen Outbreak-Ready Vaccine Production And Global Access Feb 3 (Reuters) - Samsung Biologics Co Ltd 207940.KS : CEPI AND SAMSUNG BIOLOGICS COLLABORATE TO STRENGTHEN OUTBREAK-READY VACCINE PRODUCTION AND GLOBAL ACCESS Source text: ID:nPn9NK986a Fu
02-03 21:33
UPDATE 1-Merck unit partners with global health coalition to develop affordable Ebola vaccine
UPDATE 1-Merck unit partners with global health coalition to develop affordable Ebola vaccine Updates paragraph 1 and 4 to show that it is Merck & Co unit MSD Jan 21 (Reuters) - Merck & Co MRK.N unit MSD a nd the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered o
01-22 05:53
Merck partners with global health coalition to develop affordable Ebola vaccine
Merck partners with global health coalition to develop affordable Ebola vaccine Jan 21 (Reuters) - Merck MRK.N a nd the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 million program to develop an updated version of the drugmaker's Ebola vaccine aimed
01-21 23:56
Valneva And Serum Institute Mutually Terminate Chikungunya Vaccine License; Valneva Regains Full Control To Accelerate Access In High-Risk Countries
Valneva SE ("Valneva" or "the Company"), a specialty vaccine company, and Serum Institute of India (SII), a Cyrus Poonawalla Group company today announced that they have mutually agreed to discontinue their license
01-01 00:47
BRIEF-Vaxxas And CEPI Advance US$4.8 Program For Needle-Free Thermostable mRNA Vaccines
Jan 22 (Reuters) - VAXXAS AND CEPI ADVANCE US$4.8 MILLION (AU$7.2 MILLION) PROGRAM FOR NEEDLE-FREE THERMOSTABLE MRNA VACCINES Source text: ID:nBwqWVfZa Further company coverage: [ ] (((( Reuters.Brief...
2025-01-23 01:59
